SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2024 quarter is pegged at Rs. 149.10 millions, about 7.58% up against Rs. 138.60 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -797.10 millions as compared to Net Loss of Rs. -996.50 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to -741.90% as compared to -962.30% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 149.10 138.60 7.58 445.80 589.90 -24.43 755.50 2387.80 -68.36
Other Income 1.90 63.90 -97.03 17.90 250.70 -92.86 294.70 108.80 170.86
PBIDT -741.90 -962.30 -22.90 -2715.60 -2712.00 0.13 -3743.20 -2031.80 84.23
Interest 27.70 2.60 965.38 44.00 7.80 464.10 16.60 76.30 -78.24
PBDT -769.60 -964.90 -20.24 -2759.60 -2719.80 1.46 -3759.80 -2108.10 78.35
Depreciation 27.50 31.60 -12.97 82.80 94.40 -12.29 121.30 117.70 3.06
PBT -797.10 -996.50 -20.01 -2842.40 -2814.20 1.00 -3881.10 -2225.80 74.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -797.10 -996.50 -20.01 -2842.40 -2814.20 1.00 -3881.10 -2225.80 74.37
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -497.59 -694.30 -28.33 -609.15 -459.74 32.50 -495.46 -85.09 482.27

Sun Pharma Adv. Res Share Price

143.00 -0.30 (-0.21%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 428.35
Indegene 491.95
CMS Info Systems 312.90
JITF Infralogistics 312.00
Sagility 42.16
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×